brad walsh

@SU2C Have just seen this for the first time. Way to go ! #glytherix #prostatecancer

Matt Damon is opening up the #StandUpToCancer show! He’s sharing how 10 years ago, #StandUpToCancer began as a dream. “A dream that by working together, we could turn every cancer patient into a long-term survivor.”

Have arrived at the next step in commercialisation of our #ProstateCancer diagnostic, offering US urologists another tool to inform treatment decisions & at-risk men better diagnosis in Q2 this year. Looking forward to a great partnership with Cirrus Dx bit.ly/2IdJoUZ

Great to meet with the #IDEALResearchHub team working with Minomic on next generation diagnostics and see their fantastic progress.

Precision oncology experts discuss using genomics to guide therapy. @AlvaAjjai of @UMRogelCancer and @umichmedicine #PCFRetreat18

We did it! Thanks to all of @MinomicInt for giving me the tools I needed to win the grand final in Hangzhou - now the work begins

After winning 1st prize in the recent Innovation & Entrepreneurship Competition for Overseas Talents 2018, which was held in Sydney, our CEO @drbrad69 Walsh is excited to be heading to @Hangzhou_CHINA to compete in the final round.

Another great meeting @AustProstate 19th Asia-Pacific Prostate Cancer Conference in Brisbane. Good to meet up with our friend and colleague Prof Dan Chan and to be able to present the data from Minomic International Ltd Miltuximab study #apcc18 #men #ProstateCancer #urology

Great talk Dr Mei Yeh #APCC18 @AustProstate

Poster session coming up at AdmeTech (a whole new look at Prostate Cancer) meet @manogram @micheck_test

Great to be in Chicago with ⁦@CarlStubbings for ⁦@Clin_Chem_AACC⁩ with the world beating ⁦@micheck_test⁩ ⁩

Thanks to Howard Gurney, Dhanusha Saba Macquarie University Hospital ANSTO Auspep and Macquarie Medical Imaging for their great teamwork with Minomic International Ltd in achieving this truly outstanding result lnkd.in/eJNPdCT

Looking forward to a Roundtable on Biotech in Australia on @RadioNational 9.30am Sunday with @hughriminton - should be great fun!

So pleased we bring together our clinical, regulatory, trial & business advisors around the #AUA18 in #SF & #StHelena. Thanks to @Urogill, Neal Shore, @EmbertonMark, Dan Chan, Maria Chan, @gpalapa2, John Cullity, Tom Paivanas, Arletta van Breda for your contribute to @MinomicInt

#Minomic completes Prospective Clinical Study using #MiCheck to assist in diagnosis of #ProstateCancer. •58% Fewer patients proceed to Biopsy •US Rollout well advanced businesswire.com/news/home/2018…

Minomic Completes Prospective Clinical Study Using MiCheck® to Assist in Diagnosis of Prostate Cancer | Business Wire businesswire.com/news/home/2018…

Thanks Ali twitter.com/ali_asgher_ali…

Pleasure to host both our local member @JAforBennelong and Assistant Minister @ZedSeselja @MinomicInt today to discuss our solutions for #prostatecancer diagnosis and therapy

Carl Stubbings from @MinomicInt speaking at the @_IMNIS Value of Networking meeting. “A cup of coffee is never just a cup of coffee”

Dr Doug Campbell presenting on Glypican-1 as a new target in CaP. Minomic’s @MinomicInt work with Dr Ganesh Palapattu @gpalapa2 and Dr Hans Klingemann @NantKwest

@MinomicInt Great day with Aussie and Hong Kong biotech’s and investors yesterday. Well done AusBiotech

Dr Brad Walsh, @MinomicInt CEO presenting the new spinout investment #GlyTherix with unique assets in the treatment of solid #tumors in Hong Kong at #Biotech Invest 2018, 13 March #innovation